The manufacturing plant/lab will be great for Adxs`s development,but you do realize that in the short term the overhead from it will be huge,until the company can get a drug approval and commercialization to market,which will bring in much needed revenue to replace dilution Danno`s only form of getting money to date.The street always looks at something like this as a negative on the company until it`s a positive revenue maker.The shorts obviously know this and they doubled up their shorts at the recent highs,and will do to the stock what they always do until they can`t get away with it anymore. We`re years away from being free from the plague of the shorty and it`s very frustrating to any long term investors here.